Treatment of preterm brain injury via gut-microbiota-metabolite-brain axis

Ling Li1, Tianjing Liu1, Yongyan Shi1

  • 1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.

PubMed

Insights

Gut microbiota influences preterm infant brain development and function. Optimizing gut bacteria may offer novel therapies for neurological deficits and reduce long-term sequelae.

Area of Science:

  • Neuroscience
  • Microbiology
  • Developmental Biology

Background:

  • Preterm infant brain injury disrupts neural networks, causing neurological deficits.
  • Gut microbiota (GM) and metabolites impact central nervous system (CNS) programming and function.
  • Understanding the gut-brain axis is crucial for addressing preterm infant neurodevelopmental issues.

Purpose of the Study:

  • To review mechanisms of GM-mediated effects on neural development and function.
  • To explore immune, endocrine, neural, and blood-brain barrier (BBB) pathways.
  • To summarize therapeutic strategies for preterm brain injury.

Main Methods:

  • Literature review of 150 articles.
  • Synthesis of direct and indirect GM-CNS interaction mechanisms.
  • Discussion of therapeutic interventions and their challenges.

Main Results:

  • GM influences the nervous system through various direct and indirect pathways.
  • Therapeutic interventions include probiotics, prebiotics, synbiotics, diet, and fecal transplants.
  • Potential benefits and challenges of GM-based treatments are identified.

Conclusions:

  • The microbiota-gut-brain axis offers novel therapeutic avenues for preterm infants.
  • Optimizing early gut microbiota colonization may promote brain development.
  • This approach could reduce long-term neurological sequelae in preterm infants.
Abstract